Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1986 1
1988 3
1989 6
1990 8
1991 1
1992 5
1993 7
1994 12
1995 5
1996 6
1997 11
1998 10
1999 15
2000 13
2001 10
2002 11
2003 18
2004 24
2005 22
2006 33
2007 28
2008 33
2009 38
2010 42
2011 55
2012 69
2013 57
2014 48
2015 58
2016 31
2017 43
2018 49
2019 66
2020 75
2021 76
2022 80
2023 57
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

1,057 results

Results by year

Filters applied: . Clear all
Page 1
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P; EORTC Soft Tissue and Bone Sarcoma Group; PALETTE study group. van der Graaf WT, et al. Among authors: blay jy. Lancet. 2012 May 19;379(9829):1879-86. doi: 10.1016/S0140-6736(12)60651-5. Epub 2012 May 16. Lancet. 2012. PMID: 22595799 Free article. Clinical Trial.
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
Hyman DM, Puzanov I, Subbiah V, Faris JE, Chau I, Blay JY, Wolf J, Raje NS, Diamond EL, Hollebecque A, Gervais R, Elez-Fernandez ME, Italiano A, Hofheinz RD, Hidalgo M, Chan E, Schuler M, Lasserre SF, Makrutzki M, Sirzen F, Veronese ML, Tabernero J, Baselga J. Hyman DM, et al. Among authors: blay jy. N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309. N Engl J Med. 2015. PMID: 26287849 Free PMC article. Clinical Trial.
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. Demetri GD, et al. Among authors: blay jy. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177515 Free PMC article. Clinical Trial.
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY. Penel N, et al. Among authors: blay jy. J Clin Oncol. 2008 Nov 10;26(32):5269-74. doi: 10.1200/JCO.2008.17.3146. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809609 Clinical Trial.
Metabolic landscapes in sarcomas.
Miallot R, Galland F, Millet V, Blay JY, Naquet P. Miallot R, et al. Among authors: blay jy. J Hematol Oncol. 2021 Jul 22;14(1):114. doi: 10.1186/s13045-021-01125-y. J Hematol Oncol. 2021. PMID: 34294128 Free PMC article. Review.
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.
Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Orvieto E, Sanchez J, Chevreau C, Dell'Oro S, Zucca E, Cavalli F. Ferreri AJ, et al. Among authors: blay jy. J Clin Oncol. 2003 Jan 15;21(2):266-72. doi: 10.1200/JCO.2003.09.139. J Clin Oncol. 2003. PMID: 12525518 Free article.
Sarcoma management: expertise and balance.
Blay JY. Blay JY. Future Oncol. 2021 Jul;17(21s):1. doi: 10.2217/fon-2021-0448. Epub 2021 Jun 10. Future Oncol. 2021. PMID: 34107728 No abstract available.
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q, le Cesne A, van Oosterom AT, Clemons MJ, Kamby C, Hermans C, Whittaker J, Donato di Paola E, Verweij J, Nielsen S. Judson I, et al. Among authors: blay jy. Eur J Cancer. 2001 May;37(7):870-7. doi: 10.1016/s0959-8049(01)00050-8. Eur J Cancer. 2001. PMID: 11313175 Clinical Trial.
Targeted cancer therapies.
Blay JY, Le Cesne A, Alberti L, Ray-Coquart I. Blay JY, et al. Bull Cancer. 2005 Feb;92(2):E13-8. Bull Cancer. 2005. PMID: 15749638 Free article. Review.
Osteosarcoma.
Philip T, Blay JY, Brunat-Mentigny M, Carrie C, Chauvot P, Farsi F, Fervers B, Gentet JC, Giammarile F, Kohler R, Mathoulin S, Patricot LM, Thiesse P; French National Federation of Cancer (FNCLCC). Philip T, et al. Among authors: blay jy. Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):78-80. doi: 10.1054/bjoc.2000.1770. Br J Cancer. 2001. PMID: 11355976 Free PMC article. No abstract available.
1,057 results